Liothyronine is a synthetic form of triiodothyronine (T3), the most metabolically active thyroid hormone. It has a faster onset and shorter duration than levothyroxine and is sometimes used in combination with T4, for T3-only therapy in select cases, or for short-term TSH suppression in thyroid cancer diagnostic protocols. It is not considered first-line treatment for hypothyroidism.
Can be added to T4 therapy in select non-responders
What to watch for
Tachycardia and palpitations
Tremor
Insomnia and nervousness
Untreated adrenal insufficiency
Acute myocardial infarction (unless hypothyroidism is contributory)
The bottom line
Evidence rating moderate. Most-documented uses: rapid onset of thyroid hormone action, useful when quick thyroid hormone replacement is needed, may help patients who poorly convert t4 to t3. 10 sources indexed (2015–2025), with 2 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
Synthetic T3 that directly binds nuclear thyroid hormone receptors without requiring peripheral conversion. Activates gene transcription for proteins involved in oxygen consumption, basal metabolic rate, carbohydrate and lipid metabolism, and thermogenesis. Its direct action explains the rapid onset compared to T4-based therapies.7,2
Class
Thyroid Hormone
Absorption
Best on an empty stomach
Dosing
Dosing & protocol.
Common range
5–75 mcg daily in divided doses; combination therapy typically 5–15 mcg daily (as prescribed by your physician)
Recommended form
Oral tablet; IV formulation (Triostat) for myxedema coma
Take on an empty stomach, ideally 30–60 minutes before food. Often dosed in divided doses (BID or TID) due to short half-life.
Safety
Full safety detail.
Side effects
Tachycardia and palpitations
Tremor
Insomnia and nervousness
Heat intolerance and sweating
Weight loss
Diarrhea
Angina (in patients with coronary artery disease)
Arrhythmias
Contraindications
Untreated adrenal insufficiency
Acute myocardial infarction (unless hypothyroidism is contributory)
Vitamin B7, also called biotin, does not directly change liothyronine levels, but it can distort thyroid lab tests used to monitor therapy. Many immunoassays can show falsely low TSH and falsely high T3 or T4 after high-dose biotin. This can make liothyronine dosing look excessive or make hyperthyroidism appear worse than it is.
Recommendation: Stop biotin for at least 48 to 72 hours before thyroid labs, and longer for high-dose products if your clinician or lab recommends it. Tell the lab and prescriber about any hair, skin, nail, or B-complex product that contains biotin.
Ashwagandha may increase thyroid hormone activity or trigger thyrotoxicosis in susceptible people. Liothyronine is active T3 and can cause symptoms quickly if the total thyroid hormone effect becomes too high. Combining the two may increase the chance of palpitations, tremor, anxiety, insomnia, or heat intolerance.
Recommendation: Avoid ashwagandha unless your prescriber knows you are taking liothyronine. If you start or stop ashwagandha, monitor thyroid labs and symptoms closely because liothyronine dose changes may be needed.
Bahl S, Taylor PN, Premawardhana LD et al.. Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis. The Journal of clinical endocrinology and metabolism. 2025
Nassar M, Hassan A, Ramadan S et al.. Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis. BMC endocrine disorders. 2024
Vargas-Uricoechea H, Wartofsky L. LT4/LT3 Combination Therapy vs. Monotherapy with LT4 for Persistent Symptoms of Hypothyroidism: A Systematic Review. International journal of molecular sciences. 2024
Kraut E, Farahani P. A Systematic Review of Clinical Practice Guidelines' Recommendations on Levothyroxine Therapy Alone versus Combination Therapy (LT4 plus LT3) for Hypothyroidism. Clinical and investigative medicine. Medecine clinique et experimentale. 2015
Hajtalebi F, Alaei-Shahmiri F, Golgiri F et al.. Early effects of LT3 + LT4 combination therapy on quality of life in hypothyroid patients: a randomized, double-blind, parallel-group comparison trial. BMC endocrine disorders. 2025
Azizi F, Amouzegar A, Abdi H et al.. Treatment of hypothyroidism with levothyroxine plus slow-release liothyronine: a study protocol for a randomized controlled double-blinded clinical trial. Trials. 2025
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Liothyronine in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack